BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 21158974)

  • 1. Blocking interleukin-1β in acute and chronic autoinflammatory diseases.
    Dinarello CA
    J Intern Med; 2011 Jan; 269(1):16-28. PubMed ID: 21158974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome.
    Mitroulis I; Skendros P; Ritis K
    Eur J Intern Med; 2010 Jun; 21(3):157-63. PubMed ID: 20493414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.
    Menu P; Vince JE
    Clin Exp Immunol; 2011 Oct; 166(1):1-15. PubMed ID: 21762124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating inflammation by blocking interleukin-1 in humans.
    Dinarello CA; van der Meer JW
    Semin Immunol; 2013 Dec; 25(6):469-84. PubMed ID: 24275598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of interleukin-1β in autoinflammatory diseases.
    Lachmann HJ; Quartier P; So A; Hawkins PN
    Arthritis Rheum; 2011 Feb; 63(2):314-24. PubMed ID: 20967858
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical perspective of IL-1β as the gatekeeper of inflammation.
    Dinarello CA
    Eur J Immunol; 2011 May; 41(5):1203-17. PubMed ID: 21523780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammasome and IL-1beta-mediated disorders.
    Hoffman HM; Wanderer AA
    Curr Allergy Asthma Rep; 2010 Jul; 10(4):229-35. PubMed ID: 20425006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Human Proteoglycan 4 Regulates Phagocytic Activation of Monocytes and Reduces IL-1β Secretion by Urate Crystal Stimulated Gout PBMCs.
    ElSayed S; Jay GD; Cabezas R; Qadri M; Schmidt TA; Elsaid KA
    Front Immunol; 2021; 12():771677. PubMed ID: 34992596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoinflammatory disorders, pain, and neural regulation of inflammation.
    Chen MC; Meckfessel MH
    Dermatol Clin; 2013 Jul; 31(3):461-70. PubMed ID: 23827248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies.
    Glaser RL; Goldbach-Mansky R
    Curr Allergy Asthma Rep; 2008 Jul; 8(4):288-98. PubMed ID: 18606080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.
    Dinarello CA; Simon A; van der Meer JW
    Nat Rev Drug Discov; 2012 Aug; 11(8):633-52. PubMed ID: 22850787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review.
    Cheng R; Wu Z; Li M; Shao M; Hu T
    Int J Oral Sci; 2020 Jan; 12(1):2. PubMed ID: 31900383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.
    Dinarello CA
    Blood; 2011 Apr; 117(14):3720-32. PubMed ID: 21304099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long and winding road in pharmaceutical development of canakinumab from rare genetic autoinflammatory syndromes to myocardial infarction and cancer.
    Gram H
    Pharmacol Res; 2020 Apr; 154():104139. PubMed ID: 30648616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammasome, autoinflammatory diseases, and gout.
    Pétrilli V; Martinon F
    Joint Bone Spine; 2007 Dec; 74(6):571-6. PubMed ID: 17714972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategies.
    Zhao G; Dharmadhikari G; Maedler K; Meyer-Hermann M
    PLoS Comput Biol; 2014 Aug; 10(8):e1003798. PubMed ID: 25167060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of interleukin-1β in autoinflammatory diseases.
    Lane T; Lachmann HJ
    Curr Allergy Asthma Rep; 2011 Oct; 11(5):361-8. PubMed ID: 21728024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Inflammatory Diseases with IL-1 Blockade.
    Dinarello CA
    Curr Otorhinolaryngol Rep; 2018; 6(1):1-14. PubMed ID: 33133777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoinflammatory diseases.
    Rubartelli A
    Immunol Lett; 2014 Oct; 161(2):226-30. PubMed ID: 24452074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canakinumab in gout.
    Schlesinger N
    Expert Opin Biol Ther; 2012 Sep; 12(9):1265-75. PubMed ID: 22784099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.